Related Experiment Video
Updated: Nov 8, 2025

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
Published on: July 1, 2011
Identification of potential genes associated with immune cell infiltration in atherosclerosis
Xiaodong Xia1, Manman Wang2, Jiao Li3
1Department of Emergency Medicine, Tianjin Medical University General Hospital, Tianjin City, 300052, China.
Background:
This study aimed to analyze the potential genes associated with immune cell infiltration in atherosclerosis (AS).
Methods:
Gene expression profile data (GSE57691) of human arterial tissue samples were downloaded, and differentially expressed RNAs (DERNAs; long-noncoding RNA [lncRNAs], microRNAs [miRNAs], and messenger RNAs [mRNAs]) in AS vs. control groups were selected. Based on genome-wide expression levels, the proportion of infiltrating immune cells in each sample was assessed. Genes associated with immune infiltration were selected, and subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. Finally, a competing endogenous RNA (ceRNA) network was constructed, and the genes in the network were subjected to functional analyses.
Results:
A total of 1749 DERNAs meeting the thresholds were screened, including 1673 DEmRNAs, 63 DElncRNAs, and 13 DEmiRNAs. The proportions of B cells, CD4+ T cells, and CD8+ T cells were significantly different between the two groups. In total, 341 immune-associated genes such as HBB, FCN1, IL1B, CXCL8, RPS27A, CCN3, CTSZ, and SERPINA3 were obtained that were enriched in 70 significantly related GO biological processes (such as immune response) and 15 KEGG pathways (such as chemokine signaling pathway). A ceRNA network, including 33 lncRNAs, 11 miRNAs, and 216 mRNAs, was established.
Conclusion:
Genes such as FCN1, IL1B, and SERPINA3 may be involved in immune cell infiltration and may play important roles in AS progression via ceRNA regulation.
Related Concept Videos
Atherosclerosis I: Introduction
Inflammation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

